These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
542 related items for PubMed ID: 12757688
1. The efficacy of chemoprophylaxis against malaria with chloroquine plus proguanil, mefloquine, and atovaquone plus proguanil in travelers from Denmark. Kofoed K, Petersen E. J Travel Med; 2003; 10(3):150-4. PubMed ID: 12757688 [Abstract] [Full Text] [Related]
3. Atovaquone-proguanil (malarone): an effective treatment for uncomplicated Plasmodium falciparum malaria in travelers from Denmark. Thybo S, Gjorup I, Ronn AM, Meyrowitsch D, Bygberg IC. J Travel Med; 2004 Oct; 11(4):220-3. PubMed ID: 15541224 [Abstract] [Full Text] [Related]
4. Reported side effects to chloroquine, chloroquine plus proguanil, and mefloquine as chemoprophylaxis against malaria in Danish travelers. Petersen E, Ronne T, Ronn A, Bygbjerg I, Larsen SO. J Travel Med; 2000 Oct; 7(2):79-84. PubMed ID: 10759574 [Abstract] [Full Text] [Related]
5. Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria. McKeage K, Scott L. Drugs; 2003 Oct; 63(6):597-623. PubMed ID: 12656656 [Abstract] [Full Text] [Related]
6. Vivax Malaria Chemoprophylaxis: The Role of Atovaquone-Proguanil Compared to Other Options. Meltzer E, Rahav G, Schwartz E. Clin Infect Dis; 2018 May 17; 66(11):1751-1755. PubMed ID: 29228132 [Abstract] [Full Text] [Related]
7. Malaria chemoprophylaxis regimens: a descriptive drug utilization study. Bloechliger M, Schlagenhauf P, Toovey S, Schnetzler G, Tatt I, Tomianovic D, Jick SS, Meier CR. Travel Med Infect Dis; 2014 May 17; 12(6 Pt B):718-25. PubMed ID: 24934849 [Abstract] [Full Text] [Related]
10. Comparative benefit of malaria chemoprophylaxis modelled in United Kingdom travellers. Toovey S, Nieforth K, Smith P, Schlagenhauf P, Adamcova M, Tatt I, Tomianovic D, Schnetzler G. Travel Med Infect Dis; 2014 Jun 17; 12(6 Pt B):726-32. PubMed ID: 25443997 [Abstract] [Full Text] [Related]
11. Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study. Overbosch D, Schilthuis H, Bienzle U, Behrens RH, Kain KC, Clarke PD, Toovey S, Knobloch J, Nothdurft HD, Shaw D, Roskell NS, Chulay JD, Malarone International Study Team. Clin Infect Dis; 2001 Oct 01; 33(7):1015-21. PubMed ID: 11528574 [Abstract] [Full Text] [Related]
12. Imported malaria is stable from Africa but declining from Asia. Møller CH, David K. Dan Med J; 2014 May 01; 61(5):A4827. PubMed ID: 24814737 [Abstract] [Full Text] [Related]
13. Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in nonimmune pediatric travelers: results of an international, randomized, open-label study. Camus D, Djossou F, Schilthuis HJ, Høgh B, Dutoit E, Malvy D, Roskell NS, Hedgley C, De Boever EH, Miller GB, International Malarone Study Team. Clin Infect Dis; 2004 Jun 15; 38(12):1716-23. PubMed ID: 15227617 [Abstract] [Full Text] [Related]
14. [The proper use of antimalarial drugs currently available]. Bourgeade A, Delmont J. Bull Soc Pathol Exot; 1998 Jun 15; 91(5 Pt 1-2):493-6. PubMed ID: 10078393 [Abstract] [Full Text] [Related]
15. Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers: a randomised, double-blind study. Malarone International Study Team. Høgh B, Clarke PD, Camus D, Nothdurft HD, Overbosch D, Günther M, Joubert I, Kain KC, Shaw D, Roskell NS, Chulay JD, Malarone International Study Team. Lancet; 2000 Dec 02; 356(9245):1888-94. PubMed ID: 11130385 [Abstract] [Full Text] [Related]
16. Malarone (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria. Malarone Clinical Trials Study Group. Looareesuwan S, Chulay JD, Canfield CJ, Hutchinson DB. Am J Trop Med Hyg; 1999 Apr 02; 60(4):533-41. PubMed ID: 10348225 [Abstract] [Full Text] [Related]
17. Randomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia. Ling J, Baird JK, Fryauff DJ, Sismadi P, Bangs MJ, Lacy M, Barcus MJ, Gramzinski R, Maguire JD, Kumusumangsih M, Miller GB, Jones TR, Chulay JD, Hoffman SL, Naval Medical Research Unit 2 Clinical Trial Team. Clin Infect Dis; 2002 Oct 01; 35(7):825-33. PubMed ID: 12228819 [Abstract] [Full Text] [Related]
18. Current status and replies to frequently posed questions on atovaquone plus proguanil (Malarone) for the prevention of malaria. Kain KC. BioDrugs; 2003 Oct 01; 17 Suppl 1():23-8. PubMed ID: 12785875 [Abstract] [Full Text] [Related]
19. A cluster of Plasmodium vivax malaria in an expedition group to Ethiopia: prophylactic efficacy of atovaquone/proguanil on liver stages of P. vivax. Mavrogordato A, Lever AM. J Infect; 2012 Sep 01; 65(3):269-74. PubMed ID: 22609735 [Abstract] [Full Text] [Related]
20. Atovaquone/proguanil for the prophylaxis and treatment of malaria. Patel SN, Kain KC. Expert Rev Anti Infect Ther; 2005 Dec 01; 3(6):849-61. PubMed ID: 16307498 [Abstract] [Full Text] [Related] Page: [Next] [New Search]